4 results
Approved WMOCompleted
Is the use of postoperative autologous retransfusion drainage (ARD) systems useful in hip and knee arthroplasty?
Approved WMOCompleted
To determine the pharmacokinetic properties of a new elacridar formulation
Approved WMOPending
Main objective: To determine the efficacy of pemigatinib in participants with recurrent GBM with an activating FGFR1-3 mutation or fusion/rearrangement. Secondary objectives: 1. To determine the efficacy of pemigatinib in participants with recurrent…
Approved WMORecruiting
Primary ObjectivesEvaluate the efficacy of pemigatinib versus gemcitabine plus cisplatin in the first-line treatment of participants with cholangiocarcinoma with FGFR2 rearrangement. Secundary ObjectivesEvaluate the efficacy of pemigatinib versus…